Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01826240 · ClinicalTrials.gov registry record · Phase 1
Mindfulness-Based Cognitive Therapy + Safety Planning For Suicidal Behavior
A Phase 1 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT01826240 is a Phase 1 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 20 participants.
The verdict
NCT01826240, a Phase 1 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to combine and adapt Mindfulness-Based Cognitive Therapy (MBCT) + Safety Planning Intervention (SPI) for individuals with suicidal behavior and to determine its feasibility, acceptability, safety and preliminary effectiveness. An exploratory aim is to collect data on the cognitive changes underlying treatment gains.
Interventions
- BEHAVIORAL MBCT+SPI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01826240
The ClinicalTrials.gov registry entry for NCT01826240 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MBCT+SPI is the first listed.
NCT01826240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01826240 about?
NCT01826240 is a clinical study titled "Mindfulness-Based Cognitive Therapy + Safety Planning For Suicidal Behavior". The purpose of this study is to combine and adapt Mindfulness-Based Cognitive Therapy (MBCT) + Safety Planning Intervention (SPI) for individuals with suicidal behavior and to determine its feasibility, acceptability, safety and preliminary effectiveness. An exploratory aim is to collect data on the...
What is the current status of trial NCT01826240?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2013-03. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01826240?
The interventions under investigation include: MBCT+SPI (BEHAVIORAL).
Who is sponsoring clinical trial NCT01826240?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.